Perio II

Chemotherapeutics

100

Active Ingredient in Arestin 

1.0 mg Minocycline 

200

Systemic drug of choice for aggressive perio 

Tetracycline

300

Systemic agent that can cause clostridium difficilie (c. diff)

Clindamycin 

400

Bacteria targeted by Metronidazole 

Anaerobic bacteria and spirochetes 

500

3 criteria for an effective chemotherapuetic agent 

Ability to reach disease

Delivered at bacteriostatic or bactericidal concentrations

Remain in place long enough to be effective

Let's Talk Numbers

100

Expected probe depth reduction after oral hygiene alone

0.5mm

200

Probe depth reduction expected after NSPT in a 4-6mm pocket

1.0mm

300

Attachment gain expected after NSPT in a 4-6mm pocket

0.5mm

400

Expected probe depth reduction after NSPT in 6mm+ pockets

2mm

500

Level of bone loss needed to present radiographically 

30-50%

Re-eval

100

Percentage of "acceptable" bleeding at the re-eval

<30% of initial sites

200

Optimum time to wait for a re-eval

4-6 weeks

300

Refractory disease 

Patient fails to respond to periodontal therapy 

400

People who believe what THEY do will affect their health. 

Internal locus of control 

500

Prognosis of a tooth with Grade II Furcation and moderate attachment loss

Poor

Coding

100

4910

Perio Maint

200

4341

SRP 4+ Teeth 

300

4342

SRP 1-3 Teeth 

400

4355

FMD

500

4346

Scaling in the Presence of Gingival Inflammation

Rinses

100

Oral rinse FDA approved to treat Gingivitis 

CHX

200

Main ingredient in cosmetic rinses 

Quaternary Ammonium Compounds

300

Mechanism of action of oxidizing rinses 

Effervescence--produces a gaseous oxygen where anaerobic bacteria cannot live

400

Reduces plaque 25-80%

CHX

500

The rinse best used to treat necrotizing perio (NP)

Povidone Iodine